This publication is unavailable to your account. If you have more privileged account please try to use it or contact with the institution connected to this digital library.
Lukasiewicz, Ewa
2008
Praca doktorska
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma and accounts on c.a. 5% of all malignant tumors of childhood and adolescence. Newly diagnosed patients, without metastasis, have good prognosis, while patients with metastasis, have poor outcome (the overall survival rate - c.a. 20%). The goal of this dissertation was to evaluate utility of given strategies in treatment of RMS: usage of heat shock protein 90 inhibitors - geldanamycin and its analogues, targeting the multiple cancer-causing pathways and usage of siRNA inhibiting MET receptor, known to be responsible for cancer invasion and metastasis. We found that geldanamycin causes apoptosis and cell cycle arrest, which result in RMS cells growth inhibition. Geldanamycin reduces MET-dependant invasiveness and homing into bone marrow. We observed higher sensitivity of embryonal subtype in comparison with alveolar RMS subtype to heat shock protein 90 inhibitors. We showed that MET receptor blockage results in decrease of RMS invasiveness and primary tumor growth inhibition, due to proliferation restriction, differentiation and angiogenesis reduction. It seems that the strategies described above could be of a value when considering potential, new therapeutic approaches in RMS therapy.
Kraków
2 - studia doktoranckie
onkologia
Wydział Lekarski
Majka, Marcin
2007
oai:dl.cm-uj.krakow.pl:991
ZB-107468
pol
tylko w bibliotece
Jul 19, 2022
Nov 21, 2012
29
0
http://dl.cm-uj.krakow.pl:8080/publication/991
RDF
OAI-PMH
Dulęba, Marcin
Marcinowska, Agnieszka
Gastoł, Joanna
Adamus, Tomasz
Golec, Piotr
Korpanty, Grzegorz
Nocuń, Agnieszka
Citation style: chicago-author-date iso690-author-date
This page uses 'cookies'. More information I understand